Reproductive Biology and Endocrinology

Papers
(The H4-Index of Reproductive Biology and Endocrinology is 26. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)
ArticleCitations
Does mRNA SARS-CoV-2 vaccine influence patients' performance during IVF-ET cycle?97
Growth hormone activates PI3K/Akt signaling and inhibits ROS accumulation and apoptosis in granulosa cells of patients with polycystic ovary syndrome94
Histone acetylation and the role of histone deacetylases in normal cyclic endometrium76
COVID-19 and assisted reproductive technology services: repercussions for patients and proposal for individualized clinical management74
Long non-coding RNAs (lncRNAs) in spermatogenesis and male infertility72
Increased risk of maternal and neonatal complications in hormone replacement therapy cycles in frozen embryo transfer51
Non-coding RNAs in polycystic ovary syndrome: a systematic review and meta-analysis48
Do human embryos have the ability of self-correction?46
Status of racial disparities between black and white women undergoing assisted reproductive technology in the US42
The 2019 PGDIS position statement on transfer of mosaic embryos within a context of new information on PGT-A42
Thyroid autoimmunity and IVF/ICSI outcomes in euthyroid women: a systematic review and meta-analysis42
Organoid technology in female reproductive biomedicine38
Advanced paternal age: effects on sperm parameters, assisted reproduction outcomes and offspring health38
Combined use of Diane-35 and metformin improves the ovulation in the PCOS rat model possibly via regulating glycolysis pathway33
An artificial intelligence model (euploid prediction algorithm) can predict embryo ploidy status based on time-lapse data33
Signaling mechanisms and their regulation during in vivo or in vitro maturation of mammalian oocytes32
Berberine exerts a protective effect on rats with polycystic ovary syndrome by inhibiting the inflammatory response and cell apoptosis32
Intra-ovarian injection of platelet-rich plasma into ovarian tissue promoted rejuvenation in the rat model of premature ovarian insufficiency and restored ovulation rate via angiogenesis modulation31
Correlation between steroid levels in follicular fluid and hormone synthesis related substances in its exosomes and embryo quality in patients with polycystic ovary syndrome31
Therapeutic options for premature ovarian insufficiency: an updated review31
Cryopreservation of single-sperm: where are we today?31
Polycystic ovary syndrome as a plausible evolutionary outcome of metabolic adaptation30
Decellularization and recellularization of the ovary for bioengineering applications; studies in the mouse30
Hsp90 modulates human sperm capacitation via the Erk1/2 and p38 MAPK signaling pathways30
FSH regulates RA signaling to commit spermatogonia into differentiation pathway and meiosis28
Trophoblast derived extracellular vesicles specifically alter the transcriptome of endometrial cells and may constitute a critical component of embryo-maternal communication27
BPA and BPS affect the expression of anti-Mullerian hormone (AMH) and its receptor during bovine oocyte maturation and early embryo development26
Inositol is an effective and safe treatment in polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trials26
Downregulation of hsa_circ_0005243 induces trophoblast cell dysfunction and inflammation via the β-catenin and NF-κB pathways26
UHPLC-MS-MS analysis of oxylipins metabolomics components of follicular fluid in infertile individuals with diminished ovarian reserve26
Uric acid participating in female reproductive disorders: a review26
Oocyte cryopreservation review: outcomes of medical oocyte cryopreservation and planned oocyte cryopreservation26
0.037205934524536